Cargando…
Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Although considerable research highlights the interactions between obstructive sleep apnea-hypopnea syndrome (OSAHS) and cardiovascular diseases, the effect of mandibular advancement device (MAD) treatment on cardiovascular complications in OSAHS patients remains unclear. We evaluated the effect of...
Autores principales: | Liu, Chunyan, Kang, Wenjing, Zhang, Shilong, Qiao, Xing, Yang, Xiuchun, Zhou, Zheng, Lu, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042252/ https://www.ncbi.nlm.nih.gov/pubmed/32098974 http://dx.doi.org/10.1038/s41598-020-60034-1 |
Ejemplares similares
-
Effect of mandibular advancement device treatment on HIF-1α, EPO and VEGF in the myocardium of obstructive sleep apnea–hypopnea syndrome rabbits
por: Zhu, Dechao, et al.
Publicado: (2020) -
Correlation between the Friedman Classification and the Apnea-Hypopnea Index in a population with OSAHS
por: Rodrigues, Marcos Marques, et al.
Publicado: (2015) -
Effects of adenotonsillectomy on the growth of children with obstructive sleep apnoea-hypopnea syndrome (OSAHS): protocol for a systematic review
por: Hua, Fang, et al.
Publicado: (2019) -
Drug-induced Sleep Endoscopy (DISE) with Simulation Bite to Predict the Success of Oral Appliance Therapy in Treating Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
por: Cavaliere, Matteo, et al.
Publicado: (2020) -
Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
por: Ye, Xin-Hua, et al.
Publicado: (2017)